Quick search
Popular searches:
November is Crohn’s and Colitis Awareness Month. We invite you to learn more about Dr John D. Rioux’s team work on the subject in Nature‘s article “Host|[ndash]|microbe interactions have shaped…
In a major step toward an era of personalized medicine, researchers 1000 Genomes Project, involving 700 scientists from laboratories in the U.S., Canada (including researchers in Québec), China, Japan, Nigeria…
The researchers Jacques L. Michaud (CHU Ste-Justine), Jacek Mejewski (Université McGill) and Guy A. Rouleau (CHU Ste-Justine) have discovered mutations in TMEM231 causing Joubert syndrome, a rare desease in French…
The 2012 Prix du Québec Marie-Victorin in natural science and engineering was awarded to Pr. Louis Bernatchez from Université Laval, considered by many as a world leader in the study…
The 2012 Prix du Québec Wilder Penfield has been awarded to Dr. Guy Rouleau to underline his remarkable career and his discoveries in the field of genetics. The researcher identified…
The Government of Canada and Génome Québec awards key funding for researchers at the Innovation Centre The McGill University and Génome Québec Innovation Centre will receive generous support from the…
Montreal-led international research group awarded $ 1.8 million for research on Crohn’s disease and ulcerative colitis. Dr. John D. Rioux, researcher at the Montreal Heart Institute (MHI) and Associate Professor…
During his visit to Québec City for the BioContact congress, Robert Klein of the California Institute for Regenerative Medicine, addressed the participants on the importance of funding genomics. Robert Klein,…
An article of Philip Awadalla and his team has just been published in the Journal of Epidemiology: Cohort profile of the CARTaGENE study: Quebec’s population-based biobank for public health and…
An article on Glioblastoma published in Cancer Cell : from Nada Jabado and Stefan M. Pfister http://www.cell.com/cancer-cell/abstract/S1535-6108%2812%2900364-9?switch=standard Also in Cancer cell: Methylome Alterations “Mark” New Therapeutic Opportunities in Glioblastoma http://www.cell.com/cancer-cell/abstract/S1535-6108%2812%2900403-5